Experience
SUMMARY
Our Team has accumulated over 26 years of experience in operational and quality systems for the industry and is summarized below:
Medical Devices
- Multi-national regulations, compliance and quality systems:
- QSR Part 820
- ISO 13485
- PMDA
- MDD 93/42 and 98/79
- Clinical trials: IDE (Part 812), Conducting clinical trials-CFR Parts 814,50,54 and 56, MDD 90/385
- Design control: Design history files/technical files/human factors engineering
- Regulatory filings/reports:
- 510k/PMA
- Canada MDL
- Japan PAL/MAH
- EU CE marking/Conformity
- CLIA-diagnostic/testing lab
- Annual reports- Class III
- PMA supplements/amendments
- Inspections and audits: government agencies, notified bodies, third parties, and remediation activities
- QA/Regulatory oversight of the design, manufacturing and labeling of devices, with particular expertise in the following categories:
- Infusion Pumps-Class II
- Dental Devices- Class II and III
- Plasma/Blood- Class II and III
- Regulators/Ambulatory pumps- Class II
- Enteral Nutritional Devices- Class II
- Blood banking/tracking software- Class II
- IVDD (devices)- Class II
- Single use devices (SUDs)
Pharmaceutical/Biologics
- Multi-national regulations, compliance and quality systems:
- CFR Parts 58, 210/211 and 600
- ICH Q7, Q8, Q9 and Q10
- QA oversight of Clinical Trials/CRO and Clinical Trial Material: CFR Parts 50,54,56 and 312, ICH E6
- Regulatory filings/reports:
- CMC for ANDA and NDA
- DMFs- US
- ASMFs- EU
- Annual Report/Annual Product Quality Reviews
- CBE supplement- prior approval and 30 day
- BLA
- Inspections and audits: government agencies, third parties, and remediation activities
- QA/Regulatory oversight of the manufacturing and labeling of drug/biologic products with particular expertise in the following categories:
- Plasma/Blood components and Factors
- Vaccines
- Oral products- OTC and prescription
- Topical- prescription creams and ointments
- Parenteral products:
- Antibiotics
- Anesthesia
- Cardiology
- CNS
PUBLICATIONS
“Regulatory Gaps Regarding Sugars Used in Injectable Biopharmaceuticals”,
BioPharm International, May 2006